January 23rd: The Virginia Catalyst Luncheon and Presentation
co-sponsored with VA Bio and CIT
Take advantage of this unique and free opportunity to explore current funding opportunities from the National Institute on Drug Abuse, discuss strategic recommendations for neuroscience and addiction in the Commonwealth, and benefit from a 1:1 meeting with Victor Prikhodko from NIDA to learn how to enhance your opportunity to receive SBIR funding!
|
When? Wednesday, January 23, 2019 11:30 am - 1:00 pm Where? Founders Conference Room Virginia Bio+Tech Center 800 East Leigh St, Richmond |
The National Institute on Drug Abuse (NIDA), Small Business Innovation Research program (SBIR), will award more than $45 million in FY2019 to small businesses and researchers to develop new drug discovery and development-enabling technologies, useful research tools for conducting basic research, medical devices and mobile health applications in the areas of addiction and abuse broadly. Given this enormous opportunity, its importance to the Commonwealth, and the strengths of Virginia research and commercialization, the Virginia Catalyst, Virginia Bio, and CIT are co-sponsoring a detailed briefing and workshop with presentations by NIDA and Deloitte Consulting. See "Event Details" below
Registration is required for this free event! |
Event Details
|
11:30 - Noon: Special Discussion by deloitte consulting
The Virginia Catalyst recently engaged Deloitte Consulting to explore and validate Virginia’s unmet addiction needs and benchmark Virginia’s competitive strengths and resources. Jon Baba will discuss Deloitte’s findings and strategic recommendations for neuroscience and addiction in the Commonwealth. Jon Baba, is a Principal in Deloitte’s Global Public Sector Practice and has more than 20 years of expertise in government consulting, supporting client executives focused on issues related to enterprise strategy and operational efficiency. noon - 1pm: NIDA's victor prikhodko presents rfa and sbir funding opportunities
NIDA's Victor Prikhodko, Business Advisor to the Office of Translational Initiatives and Program Innovations (OTIPI) will discuss NIDA’s SBIR funding opportunities including the recently released RFAs, “HEAL Initiative: America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis” (see links below for details), and present some best practices for strong applications. Victor Prikhodko is a Business Advisor within the Office of Translational Initiatives and Program Innovations (OTIPI) which supports the National Institute on Drug Abuse (NIDA) and administers a $45M/Y Small Business Fund (SBIR/STTR Programs). Through the program, NIDA has invested in small businesses developing substance abuse products and services ranging from therapeutics, research tools, diagnostics, medical devices, and health IT to education.
Unique opportunity for a 1:1 meeting with victor prikhodko
Before and after his presentation, Mr. Prikhodko will be available for 30- minute one-on-one meetings to discuss NIDA’s SBIR funding opportunities and to provide your company specific advice on best practices for strong applications and how to enhance your opportunity to receive funding. Meetings are scheduled on a first-come, first-serve basis. To schedule a one-to-one meeting with Mr. Prikhodko contact: Suzänne Taylor staylor@VirginiaCatalyst.org 804.937.3919 |
About the Virginia Catalyst
We are a not-for-profit 501(c)(3) corporation created by the Virginia General Assembly and funded by the Commonwealth’s General Fund and seven Virginia public research universities: Eastern Virginia Medical School, George Mason University, Old Dominion University, University of Virginia, Virginia Commonwealth University, Virginia Tech and William & Mary.
Our Mission
Our mission is to advance economic development by creating competitive critical mass for Virginia life sciences through collaborations with our research universities and industry, to attract research and commercialization capital to Virginia and to catalyze the commercialization of Virginia’s innovations that meet large, unmet medical needs, improve human health and to create many more high-paying life science jobs in Virginia.
Our goal is to have the Commonwealth of Virginia be the very best in the nation at translational medicine and commercialization. We will achieve this by teaming up the biosciences industry with our world-class academic researchers and focusing efforts on solving large unmet medical needs.
– Michael Grisham, CEO
Our Strategic Initiatives - Actions and Results for Virginia
At the Virginia Catalyst we specialize in developing and leading strategic initiatives in areas were Virginia can be a national and global leader. We support these initiatives with grant funding for collaborative projects, investments creating research tools, and infrastructure that provide our research universities, healthcare systems and companies a competitive advantage over other regions in the country.
Grant Funding
Continuing powerful impact through our Grant Funding
Grant funding for collaborations of universities and industry on commercialization projects
The Virginia Catalyst continues to hold competitive grant funding rounds for collaborations of universities and industry on commercialization projects. Our Grant Funding program has brought Virginia a 10-to-1 return on investment!
Our Cumulative Four Year Impact (2014–18)
$13.8 million in milestone-based grants awarded to
27 projects involving 6 universities and 23 companies, bringing in immediately
$31.2 million in matching funds from private industry, then
$137.88 million in follow-on funding for those companies, and creating
145 new high paying jobs in Virginia
Grant funding for collaborations of universities and industry on commercialization projects
The Virginia Catalyst continues to hold competitive grant funding rounds for collaborations of universities and industry on commercialization projects. Our Grant Funding program has brought Virginia a 10-to-1 return on investment!
Our Cumulative Four Year Impact (2014–18)
$13.8 million in milestone-based grants awarded to
27 projects involving 6 universities and 23 companies, bringing in immediately
$31.2 million in matching funds from private industry, then
$137.88 million in follow-on funding for those companies, and creating
145 new high paying jobs in Virginia
Neuroscience Initiative
Building the infrastructure to support greater success and impact
Creating systems and relationships to act as a whole, with a greater potential than any of the parts
We are bringing Virginia’s researchers, professors, healthcare providers, university students, and industry partners together to create critical mass for scientific, medical and commercial collaborations with a unique and innovate approach:
• 22 different Interest Groups formed totaling > 1,100 members holding monthly meetings
• MOU signed by Virginia research universities to readily share core facilities / resources
Creating systems and relationships to act as a whole, with a greater potential than any of the parts
We are bringing Virginia’s researchers, professors, healthcare providers, university students, and industry partners together to create critical mass for scientific, medical and commercial collaborations with a unique and innovate approach:
• 22 different Interest Groups formed totaling > 1,100 members holding monthly meetings
• MOU signed by Virginia research universities to readily share core facilities / resources
